It is not intended for human consumption , veterinary use, diagnostic use, therapeutic use, clinical use, metabolic use, weight-loss use, or use as a food, drug, cosmetic, supplement, or household product
Real-world outcomes from clinical practice often mirror trial results, though individual responses depend on starting weight, age, activity level, and medication adherence
In December 2025, Eli Lilly announced $3 billion expansion of its Wisconsin facility to meet surging demand for GLP-1 drugs like Zepbound and Mounjaro
Development of clinical criteria for functional assessment to predict primary nonfunction of highrisk livers using normothermic machine perfusion
If you're evaluating GLPatch because you want to avoid injections, the conversation now has more options in it than it used to